Symptomatology of carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy

OBJECTIVE: To ascertain whether adverse effects experienced by people taking carbamazepine or oxcarbazepine could be attributed to carbamazepine‐ or oxcarbazepine‐induced hyponatremia (COIH). METHODS: We performed an observational study, collecting data between 2017 and 2019 on serum sodium levels a...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghuis, Bianca, Hulst, Janic, Sonsma, Anja, McCormack, Mark, de Haan, Gerrit‐Jan, Sander, Josemir W., Lindhout, Dick, Koeleman, Bobby P. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248112/
https://www.ncbi.nlm.nih.gov/pubmed/33576502
http://dx.doi.org/10.1111/epi.16828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248112/
https://www.ncbi.nlm.nih.gov/pubmed/33576502
http://dx.doi.org/10.1111/epi.16828

Ejemplares similares